Skip to content
Open access

A-66: The Risk of Anosognosia: Insight Deficits Predict and Moderate Dementia Conversion in Mild Cognitive Impairment

Oct 2026 · Archives of Clinical Neuropsychology · 0 citations

Abstract

Objective: Anosognosia, or reduced awareness of one's cognitive difficulties, may differentiate mild cognitive impairment (MCI) presentations and predict dementia conversion. This study examined whether anosognosia predicted MCI-to-dementia conversion above and beyond cognitive performance and whether it moderated the relationship between cognitive performance and conversion. Method/Data Selection: 55 patients diagnosed with MCI at a memory clinic completed follow-up evaluations with complete caregiver data. 23.6% converted to dementia during repeat evaluation (mean interval = 27.1 months). Anosognosia was operationalized as the difference between caregiver- and self-rated AD8 Dementia Screening Interview (AD8) scores. Hierarchical logistic regression examined baseline Montreal Cognitive Assessment (MoCA) performance, AD8 discrepancy, and their interaction as predictors of conversion, controlling for age. Results/Data Synthesis: Age did not predict conversion (p=.916). MoCA predicted conversion (OR=0.682, 95% CI [0.502, 0.926], p=.014). AD8 discrepancy (OR=2.271, 95% CI [1.313, 3.929], p=.003) predicted conversion above and beyond MoCA. A significant MoCA × AD8 discrepancy interaction indicated that the predictive effect of insight deficits on conversion strengthened at higher MoCA scores (OR=1.141, 95% CI [1.023, 1.272], p=.017). The final model explained 45% of variance (Nagelkerke R2=.451). Conclusions: Anosognosia predicted conversion beyond cognitive performance and moderated its protective effect, suggesting that MoCA scores alone may underestimate risk, particularly when insight deficits are present. Brief informant-based insight measures may be a practical addition to prognostic screening, especially in patients with relatively intact MoCA scores. Given the modest sample size, replication in larger samples is needed before routine clinical application.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.